Combination of Photodynamic Therapy with Anti-Cancer Agents
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1655-1673
Author(s):
M.-F. Zuluaga and N. Lange
Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Journal:
Current Drug Metabolism
Volume:
9
Page:
520-531
Author(s):
Jose A.G Agundez
Apoptosis in Sepsis: Mechanisms, Clinical Impact and Potential Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1853-1859
Author(s):
Alfred Ayala, Mario Perl, Fabienne Venet, Joanne Lomas-Neira, Ryan Swan and Chun-Shiang Chung
Therapeutic Drug Monitoring of Busulfan in Transplantation
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1936-1949
Author(s):
J. A. Russell and S. B. Kangarloo
The Use of Growth Factors in Hematopoietic Stem Cell Transplantation
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1950-1961
Author(s):
I. Pusic and J. F. DiPersio
Non-Pharmacologic Strategies in Hematopoietic Stem Cell Transplantation
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1987-1996
Author(s):
Jennifer Schneiderman
An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2023-2039
Author(s):
Paolo Macor, Erika Secco, Sonia Zorzet, Claudio Tripodo, Claudio Celeghini and Francesco Tedesco
Potential Therapeutic Applications of miRNA-Based Technology in Hematological Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2040-2050
Author(s):
Elisa Barbarotto and George A. Calin
Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2051-2060
Author(s):
M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps
Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2061-2074
Author(s):
Wim J. van Blitterswijk and Marcel Verheij